Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | lamin | 0.0027 | 1 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0025 | 0.8593 | 0.5 |
Echinococcus granulosus | lamin | 0.0027 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.8593 | 0.8593 |
Echinococcus granulosus | intermediate filament protein | 0.0027 | 1 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.8593 | 0.5 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0027 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0027 | 1 | 1 |
Loa Loa (eye worm) | intermediate filament protein | 0.0027 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.8593 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 0.9606 | 0.9606 |
Leishmania major | hypothetical protein, conserved | 0.0025 | 0.8593 | 0.5 |
Onchocerca volvulus | 0.0027 | 1 | 0.5 | |
Echinococcus multilocularis | lamin dm0 | 0.0027 | 1 | 0.5 |
Brugia malayi | hypothetical protein | 0.0025 | 0.8593 | 0.8593 |
Echinococcus multilocularis | musashi | 0.0027 | 1 | 0.5 |
Schistosoma mansoni | lamin | 0.0027 | 1 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0025 | 0.8593 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0025 | 0.8593 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0025 | 0.8593 | 0.5 |
Echinococcus granulosus | lamin dm0 | 0.0027 | 1 | 0.5 |
Brugia malayi | hypothetical protein | 0.0016 | 0.1458 | 0.1458 |
Onchocerca volvulus | 0.0027 | 1 | 0.5 | |
Schistosoma mansoni | intermediate filament proteins | 0.0027 | 1 | 0.5 |
Echinococcus multilocularis | lamin | 0.0027 | 1 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0025 | 0.8593 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0027 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.